Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

NovoCure Stock News

NVCRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Thu Apr 24th, before the market open

The most recent conference call was at 8:00 AM, 1 day ago Click to view past webcast

NovoCure (NVCR) Forecast

News

Earnings NovoCure (NVCR) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest NovoCure Stock News | NASDAQ:NVCR | Benzinga

Get the latest news on NovoCure stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on NovoCure performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, April 24, 2025

NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025
Vandana Singh - 22 hours ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - 1 day ago
NovoCure Q1 EPS $(0.31) Beats $(0.46) Estimat...
Benzinga Newsdesk - 1 day ago
Earnings Scheduled For April 24, 2025
Benzinga Insights - 1 day ago

Wednesday, April 23, 2025

NovoCure's Earnings: A Preview
Benzinga Insights - 1 day ago
Piper Sandler Maintains Overweight on NovoCur...
Benzinga Newsdesk - 1 day ago

Tuesday, April 22, 2025

Novocure's Optune Lua Receives CE Mark Approv...
Benzinga Newsdesk - 3 days ago

Wednesday, April 16, 2025

Wedbush Maintains Neutral on NovoCure, Lowers...
Benzinga Newsdesk - Apr 16, 2025, 10:08AM

Thursday, April 10, 2025

JP Morgan Maintains Neutral on NovoCure, Lowe...
Benzinga Newsdesk - Apr 10, 2025, 9:41AM

Thursday, February 27, 2025

NovoCure Reports Wider Than Expected Q4 Loss Despite 21% Jump In Sales, Expects Product Enhancements To Hit Gross Margin In 2025
Vandana Singh - Feb 27, 2025, 2:33PM
NovoCure shares are trading lower after the c...
Benzinga Newsdesk - Feb 27, 2025, 11:03AM
NovoCure Q4 2024 GAAP EPS $(0.61) Misses $(0....
Benzinga Newsdesk - Feb 27, 2025, 7:01AM
Earnings Scheduled For February 27, 2025
Benzinga Insights - Feb 27, 2025, 3:32AM

Thursday, January 30, 2025

Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business'
Avi Kapoor - Jan 30, 2025, 8:46AM

Tuesday, January 14, 2025

Deep Dive Into NovoCure Stock: Analyst Perspectives (7 Ratings)
Benzinga Insights - Jan 14, 2025, 8:01AM
HC Wainwright & Co. Reiterates Buy on NovoCur...
Benzinga Newsdesk - Jan 14, 2025, 7:37AM

Monday, January 13, 2025

Novocure Reports Preliminary Net Revenues For...
Benzinga Newsdesk - Jan 13, 2025, 7:16AM
Novocure Reports Preliminary Net Revenues For...
Benzinga Newsdesk - Jan 13, 2025, 7:15AM

Sunday, December 15, 2024

Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?
Lekha Gupta - Dec 15, 2024, 10:00AM

Friday, December 13, 2024

NovoCure shares are trading higher after Pipe...
Benzinga Newsdesk - Dec 13, 2024, 3:49PM
Piper Sandler Maintains Overweight on NovoCur...
Benzinga Newsdesk - Dec 13, 2024, 8:12AM

Sunday, December 08, 2024

SoundHound, Asana And Victorias Secret Are Among Top 10 Mid Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?
Lekha Gupta - Dec 8, 2024, 10:15AM

Tuesday, December 03, 2024

HC Wainwright & Co. Maintains Buy on NovoCure...
Benzinga Newsdesk - Dec 3, 2024, 7:26AM

Monday, December 02, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Dec 2, 2024, 4:05PM
Dow Dips 150 Points; ISM Manufacturing PMI Tops Estimates
Avi Kapoor - Dec 2, 2024, 12:44PM
HC Wainwright & Co. Reiterates Buy on NovoCur...
Benzinga Newsdesk - Dec 2, 2024, 11:56AM
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
Avi Kapoor - Dec 2, 2024, 10:56AM
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
Vandana Singh - Dec 2, 2024, 10:12AM
This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Avi Kapoor - Dec 2, 2024, 8:47AM
NocoCure shares are trading higher after the ...
Benzinga Newsdesk - Dec 2, 2024, 8:35AM
Novocure Says Phase 3 PANOVA-3 Trial Met Its ...
Benzinga Newsdesk - Dec 2, 2024, 7:02AM
Navigating 5 Analyst Ratings For NovoCure
Benzinga Insights - Dec 2, 2024, 7:00AM
Evercore ISI Group Upgrades NovoCure to Outpe...
Benzinga Newsdesk - Dec 2, 2024, 6:50AM

Thursday, November 21, 2024

HC Wainwright & Co. Reiterates Buy on NovoCur...
Benzinga Newsdesk - Nov 21, 2024, 12:58PM
The FDA Approves Novocure's New Head Flexible...
Benzinga Newsdesk - Nov 21, 2024, 7:05AM

Thursday, October 31, 2024

HC Wainwright & Co. Reiterates Buy on NovoCur...
Benzinga Newsdesk - Oct 31, 2024, 5:35AM

Wednesday, October 30, 2024

Novocure Announced That Christoph Brackmann H...
Benzinga Newsdesk - Oct 30, 2024, 7:29AM
NovoCure Q3 2024 GAAP EPS $(0.28) Beats $(0.3...
Benzinga Newsdesk - Oct 30, 2024, 7:01AM

Wednesday, October 16, 2024

Deep Dive Into NovoCure Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights - Oct 16, 2024, 1:00PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Oct 16, 2024, 8:10AM
NovoCure shares are trading higher after the ...
Benzinga Newsdesk - Oct 16, 2024, 7:39AM
US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips
Shanthi Rexaline - Oct 16, 2024, 7:29AM
FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients
Vandana Singh - Oct 16, 2024, 7:28AM
HC Wainwright & Co. Upgrades NovoCure to Buy,...
Benzinga Newsdesk - Oct 16, 2024, 6:13AM

Tuesday, October 15, 2024

Novocure Says FDA Approved Optune Lua For Tre...
Benzinga Newsdesk - Oct 15, 2024, 4:44PM
NovoCure shares are trading higher after the ...
Benzinga Newsdesk - Oct 15, 2024, 4:39PM
NovoCure Announces FDA Approval Of Optune Lua...
Benzinga Newsdesk - Oct 15, 2024, 4:09PM

Monday, October 07, 2024

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - Oct 7, 2024, 1:35PM

Tuesday, October 01, 2024

Evercore ISI Group Maintains In-Line on NovoC...
Benzinga Newsdesk - Oct 1, 2024, 12:55PM

Tuesday, September 03, 2024

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor - Sep 3, 2024, 1:41PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved